CBG

Cannabigerol is derived from CBGA (cannabigerol acid) and is one of the cannabinoids, just like CBD or THC. CBG has the ability to bind to the receptors of many organs and tissues and thus modify inflammatory reactions and cellular processes. Due to its weak binding, CBG does not activate CB1 receptors and also prevents the binding of THC molecules, thereby inhibiting the psychotropic effect of THC. The most common benefits of CBG include supporting the treatment of inflammatory diseases in the intestines, stimulating appetite or supporting cancer treatment.